Compare CGEM & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEM | OXM |
|---|---|---|
| Founded | 2016 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 603.5M |
| IPO Year | 2021 | N/A |
| Metric | CGEM | OXM |
|---|---|---|
| Price | $10.76 | $37.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | $28.00 | ★ $43.60 |
| AVG Volume (30 Days) | ★ 1.4M | 594.7K |
| Earning Date | 11-06-2025 | 12-10-2025 |
| Dividend Yield | N/A | ★ 7.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,493,854,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.68 | $30.57 |
| 52 Week High | $13.33 | $89.86 |
| Indicator | CGEM | OXM |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 50.64 |
| Support Level | $10.01 | $30.57 |
| Resistance Level | $13.10 | $41.06 |
| Average True Range (ATR) | 1.04 | 2.20 |
| MACD | -0.04 | -0.18 |
| Stochastic Oscillator | 25.57 | 62.19 |
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.